Camlin Fine Sciences Ltd — Regulatory Filings 2021

Nov 2, 2021

==> picture [100 x 31] intentionally omitted <==

Date: November 2, 2021

||To,BSE Limited,25, P. J. Towers,Dalal Street,Mumbai – 400 001**Ref:**Company Scrip Code: 532834|To,The Manager,Listing Department,National Stock Exchange of India Ltd.,Exchange Plaza, Bandra Kurla Complex,Bandra (East), Mumbai‐ 400051**Ref:Symbol:**CAMLINFINE || Series: EQ| |---|---|---|

Dear Sir/Madam,

Sub: Intimation about the Board Meeting of Camlin Fine Sciences Limited (the “Company”) to be held on November 12, 2021

Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 12, 2021, inter alia ,to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and half‐year ended September 30, 2021.

Further, the Company has vide its letter dated September 28, 2021 intimated regarding the closure of the Trading Window for trading in the Company’s equity shares from October 1 2021, till the expiry of 48 hours from the date the said financial results are made public.

We request you to take the above on record and disseminate the same on your website.

Thanking you, Yours faithfully, For Camlin Fine Sciences Limited

==> picture [55 x 52] intentionally omitted <==

==> picture [106 x 51] intentionally omitted <==

Santosh Parab Chief Financial Officer

==> picture [426 x 57] intentionally omitted <==